AYVAKIT (avapritinib) for the Treatment of Gastrointestinal Stromal Tumour (GIST)

Avapritinib is indicated for the treatment of unresectable or metastatic gastrointestinal stromal tumour (GIST). Credit: Blueprint Medicines Corporation.